SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -73.25% | +1805.13% | -78.24% | +71.02% | +58.81% |
| Weighted Average Shares Diluted Growth | -73.25% | +1805.13% | -78.24% | +71.02% | +58.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +227.79% | +212.46% | +43.06% | +113.67% | +94.51% |
| Book Value per Share Growth | +0.00% | +0.00% | +1217.34% | +424.90% | +80.79% |
| Debt Growth | -10.56% | +10.49% | +8.61% | +6.50% | +3.99% |
| R&D Expense Growth | -24.96% | -12.95% | -37.29% | -25.36% | -3.35% |
| SG&A Expenses Growth | -16.38% | -19.45% | -36.97% | +23.29% | -3.37% |